Dr_Tabb

Incoming Buying Opportunity

NASDAQ:REGN   Regeneron Pharmaceuticals, Inc.
REGN potentially coming into $460 range again.
R/R heavy in favor going long if it falls to this level.
Would keep watch.
Recent phase 3 results re:COVID19
免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。